Twin Lakes Capital Management’s Amicus Therapeutics FOLD Stock Holding History

Twin Lakes Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,000	Closed	-$85.4K	–	223
2025 Q4	$85.4K	Hold	6,000	–	–	0.04%	107
2025 Q3	$47.3K	Hold	6,000	–	–	0.02%	135
2025 Q2	$34.4K	Hold	6,000	–	–	0.02%	146
2025 Q1	$49K	Hold	6,000	–	–	0.03%	126
2024 Q4	$56.5K	Hold	6,000	–	–	0.04%	133
2024 Q3	$64.1K	Hold	6,000	–	–	0.04%	126
2024 Q2	$59.5K	Hold	6,000	–	–	0.04%	128
2024 Q1	$70.7K	Hold	6,000	–	–	0.05%	122
2023 Q4	$85.1K	Hold	6,000	–	–	0.06%	109
2023 Q3	$73K	Hold	6,000	–	–	0.05%	114
2023 Q2	$75.4K	Hold	6,000	–	–	0.05%	118
2023 Q1	$66.5K	Hold	6,000	–	–	0.05%	120
2022 Q4	$73.3K	Hold	6,000	–	–	0.06%	115
2022 Q3	$63K	Hold	6,000	–	–	0.05%	125
2022 Q2	$64K	Hold	6,000	–	–	0.05%	101
2022 Q1	$57K	Hold	6,000	–	–	0.03%	146
2021 Q4	$69K	Hold	6,000	–	–	0.04%	141
2021 Q3	$57K	Hold	6,000	–	–	0.03%	144
2021 Q2	$58K	Hold	6,000	–	–	0.03%	129
2021 Q1	$59K	Buy	+6,000	New	+$92.9K	0.04%	120

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Twin Lakes Capital Management's FOLD Position: Q1 2026 in Review

Twin Lakes Capital Management sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 6,000 shares — an estimated $85.4K sold.

Twin Lakes Capital Management first reported a position in FOLD in Q1 2021 and held it in 20 quarters. The position peaked at $85.4K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Twin Lakes Capital Management reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
Twin Lakes Capital Management sold 6,000 Amicus Therapeutics shares in Q1 2026, an estimated $85.4K.
Twin Lakes Capital Management first reported a position in Amicus Therapeutics in Q1 2021 and held it in 20 quarters.
Twin Lakes Capital Management's Amicus Therapeutics position peaked at $85.4K in Q4 2025.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Twin Lakes Capital Management's 13F filing for Q1 2026, filed 18 May 2026.